NewAmsterdam Pharma Company N.V. Stock Deutsche Boerse AG
Stocks
KH6
NL00150012L7
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.33 EUR | +3.48% |
|
-10.66% | -3.09% |
| Market Cap | 3.04B 3.47B 2.81B 2.58B 4.88B 334B 4.95B 33.6B 13.17B 164B 13.02B 12.74B 564B | P/E 2026 * |
-16.7x | P/E 2027 * | -19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 2.64B 3.01B 2.44B 2.24B 4.23B 290B 4.3B 29.16B 11.43B 142B 11.3B 11.06B 489B | EV / Sales 2026 * |
113x | EV / Sales 2027 * | 18.8x |
| Free-Float |
99.09% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: NewAmsterdam Pharma Company N.V.
| 1 day | +3.48% | ||
| 1 week | -10.66% | ||
| Current month | -6.24% | ||
| 1 month | +6.97% | ||
| 3 months | +0.51% | ||
| 6 months | +1.98% | ||
| Current year | -3.09% |
| 1 week | 25.76 |  | 28.62 |
| 1 month | 24.73 | | 31.44 |
| Current year | 23.03 | | 32.68 |
| 1 year | 17.5 | | 35 |
| 3 years | 5.4 | | 35 |
| 5 years | 5.4 | | 35 |
| 10 years | 5.4 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Davidson
CEO | Chief Executive Officer | 69 | 2022-10-31 |
Mayur Somaiya
DFI | Director of Finance/CFO | 52 | 2023-10-22 |
Douglas Kling
COO | Chief Operating Officer | 53 | 2021-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Davidson
BRD | Director/Board Member | 69 | 2022-10-31 |
John Kastelein
BRD | Director/Board Member | 72 | 2022-10-31 |
James Topper
BRD | Director/Board Member | 64 | 2022-10-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.48% | -10.66% | - | - | 3.7B | |
| +0.21% | -0.79% | +53.17% | +57.39% | 53.83B | |
| +5.37% | +0.75% | +50.39% | +83.03% | 52.1B | |
| -1.20% | -1.94% | +4.35% | +402.68% | 23.48B | |
| +0.74% | +2.32% | -16.23% | -14.44% | 23.13B | |
| +3.46% | +0.79% | +34.01% | -4.47% | 19.36B | |
| -1.18% | -1.15% | +30.12% | -32.02% | 17.56B | |
| -1.67% | -8.56% | +163.95% | +284.69% | 15.2B | |
| +3.62% | -2.42% | +29.70% | +663.64% | 14.83B | |
| -0.70% | -0.91% | +24.87% | +179.47% | 14.06B | |
| Average | +1.21% | -1.98% | +41.59% | +179.99% | 25.95B | |
| Weighted average by Cap. | +1.51% | -1.96% | +41.46% | +139.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 23.43M 26.74M 21.66M 19.92M 37.59M 2.58B 38.19M 259M 102M 1.26B 100M 98.21M 4.35B | 133M 152M 123M 113M 213M 14.63B 217M 1.47B 576M 7.16B 570M 557M 24.66B |
| Net income | -191M -218M -176M -162M -306M -21B -311M -2.11B -827M -10.28B -818M -800M -35.41B | -168M -191M -155M -143M -269M -18.47B -274M -1.86B -727M -9.04B -719M -703M -31.13B |
| Net Debt | -402M -459M -371M -342M -645M -44.22B -655M -4.44B -1.74B -21.63B -1.72B -1.68B -74.54B | -538M -614M -497M -458M -863M -59.21B -877M -5.95B -2.33B -28.97B -2.31B -2.26B -99.81B |
| Date | Price | Change |
|---|---|---|
| 26-07-20 | €27.33 | +3.48% |
| 26-07-17 | €26.41 | -3.68% |
| 26-07-16 | €27.42 | -1.47% |
| 26-07-15 | €27.83 | -2.76% |
| 26-07-14 | €28.62 | -3.08% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NAMS Stock
- KH6 Stock
Select your edition
All financial news and data tailored to specific country editions
